Masashi Kasajima
Sagamihara, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
The Glasgow Prognostic Score Predicts Outcomes of Pembrolizumab or Atezolizumab Monotherapy in Patients with Pretreated Non-Small Cell Lung Cancer.
Journal: Oncology
Published: August 17, 2022
Real-World Data Analysis of Pembrolizumab Monotherapy for NSCLC Using Japanese Postmarketing All-Case Surveillance Data.
Journal: JTO clinical and research reports
Published: August 11, 2022
Combination carboplatin and nab-paclitaxel as a first-line treatment for advanced thymic carcinoma.
Journal: Investigational new drugs
Published: May 17, 2022
First-line osimertinib for poor performance status patients with EGFR mutation-positive non-small cell lung cancer: A prospective observational study.
Journal: Investigational new drugs
Published: October 12, 2021
A Prospective Observational Study of Osimertinib for Chemo-Naive Elderly Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer.
Journal: Cancer management and research
Published: September 22, 2021
Real-world assessment of afatinib for patients with EGFR-positive non-small cell lung cancer.
Journal: Investigational new drugs
Published: April 23, 2020
Impact of Amrubicin Monotherapy as Second-Line Chemotherapy on Outcomes in Elderly Patients with Relapsed Extensive-Disease Small-Cell Lung Cancer.
Journal: Cancer management and research
Published: March 26, 2020
Current status and progress of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer prior to the approval of durvalumab.
Journal: Thoracic cancer
Published: November 12, 2019
Impact of EGFR genotype on the efficacy of osimertinib in EGFR tyrosine kinase inhibitor-resistant patients with non-small cell lung cancer: a prospective observational study.
Journal: Cancer management and research
Published: February 28, 2019
Evaluation of osimertinib efficacy according to body surface area and body mass index in patients with non-small cell lung cancer harboring an EGFR mutation: A prospective observational study.
Journal: Thoracic cancer
Published: January 04, 2019
Prognostic significance of the 8th edition of the TNM classification for patients with extensive disease small cell lung cancer.
Journal: Cancer management and research
Published: December 13, 2018
Last Updated: 09/26/2026